Nuzenio

Lexicon Pharmaceuticals Completes

Lexicon Pharmaceuticals Completes news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highl - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:48:23 GMTFMR LLC (LXRX) discloses 11.7% Lexicon Pharmaceuticals stake in amended 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:32:36 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - quiverquant.comquiverquant.com · Thu, 06 Aug 2026 11:44:00 GMTLexicon Pharma (Nasdaq: LXRX) swings to $31.8M Q2 2026 loss - Stock TitanStock Titan · Thu, 06 Aug 2026 11:33:50 GMTLexicon schedules Aug. 6 call and webcast for Q2 results - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMTLexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative - SahmSahm · Tue, 28 Jul 2026 07:00:00 GMTLexicon (LXRX) Completes Patient Randomization in Key Phase 3 Tr - GuruFocusGuruFocus · Mon, 27 Jul 2026 14:11:24 GMTLexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 00:48:23 GMTLexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highl - GuruFocus
Thu, 06 Aug 2026 14:32:36 GMTFMR LLC (LXRX) discloses 11.7% Lexicon Pharmaceuticals stake in amended 13G - Stock Titan
Thu, 06 Aug 2026 11:44:00 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - quiverquant.com
Thu, 06 Aug 2026 11:33:50 GMTLexicon Pharma (Nasdaq: LXRX) swings to $31.8M Q2 2026 loss - Stock Titan
Thu, 30 Jul 2026 12:30:00 GMTLexicon schedules Aug. 6 call and webcast for Q2 results - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTLexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative - Sahm

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lexicon Pharmaceuticals Completes.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.